HomePodcastsThe Long Run with Luke TimmermanEp188: Art Krieg on Innate Immune System Activators for CancerThe Long Run with Luke TimmermanEp188: Art Krieg on Innate Immune System Activators for CancerOctober 28, 2025 · 1 h 9 minPlay episodeShare from this pointShow notesArt Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.All episodes of The Long Run with Luke Timmerman